Andrew Barros

Dr. Andrew Barros


Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in The American Journal of the Medical Sciences
Verified
Journal Article
Closed access
ABAndrew Barros
Andrew Barros
JOJustin Oldham
Justin Oldham
INImre Noth
Imre Noth

12 January 2024 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Verified
Journal Article
Open access
KLKevin Lonabaugh
Kevin Lonabaugh
GLGalvin Li
Galvin Li
RLRhonda List
Rhonda List
RHReyna Huang
Reyna Huang
AJAmber James
Amber James
DADana Albon
Dana Albon
Introduction: The introduction of the highly effective modulator therapy elexacaftor‐tezacaftor‐ivacaftor (ETI) has revolutionized the care of persons with cystic fibrosis (PwCF) with major improvements seen in lung function and body mass index. The effects of ETI therapy in real‐world cohorts on other parameters such as cholesterol levels are largely unknown.Methods: A single‐center, retrospective chart review study was conducted to assess the change in lipid panels before and after ETI initiation. The study investigated total cholesterol (TC), low‐density lipoprotein cholesterol (LDL‐C), high‐density lipoprotein cholesterol (HDL‐C), and triglyceride levels using both a univariate and multivariate mixed‐effects model to evaluate the change after initiation of ETI in a cohort of PwCF.Results: There were 128 adult PwCF included in the analysis. Statistically significant changes were seen in both univariate and multivariate analyses for TC, LDL‐C, and HDL‐C. On multivariate analysis, TC increased by an average of 15.0 mg/dL after ETI initiation (p < 0.0001), LDL‐C increased by an average of 9.3 mg/dL (p < 0.001), and HDL‐C increased by an average of 3.8 mg/dL (p < 0.001) after ETI initiation.Conclusion: In this real‐world cohort of PwCF, cholesterol parameters increased after initiation with ETI therapy. Further consideration may need to be given for PwCF in regards to screening for cardiometabolic risk factors as PwCF age as well as the potential need for cholesterol‐lowering therapies.

7 April 2023 in Emergency Medicine Clinics of North America
Verified
Journal Article
Closed access
ABAndrew Barros
Andrew Barros
KEKyle B. Enfield
Kyle B. Enfield

1 May 2023 in Critical Care Medicine
Verified
Journal Article
Closed access
JWJ. Christian Widere
J. Christian Widere
CDClaire Leilani Davis
Claire Leilani Davis
JLJohanna Jean Loomba
Johanna Jean Loomba
TBTaison D. Bell
Taison D. Bell
KEKyle B. Enfield
Kyle B. Enfield
OCon behalf of the N3C Consortium
on behalf of the N3C Consortium
OBJECTIVE: To investigate temporal trends and outcomes associated with early antibiotic prescribing in patients hospitalized with COVID-19. DESIGN: Retrospective propensity-matched cohort study using the National COVID Cohort Collaborative (N3C) database. SETTING: Sixty-six health systems throughout the United States that were contributing to the N3C database. Centers that had fewer than 500 admissions in their dataset were excluded. PATIENTS: Patients hospitalized with COVID-19 were included. Patients were defined to have early antibiotic use if they received at least 3 calendar days of intravenous antibiotics within the first 5 days of admission. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Of 322,867 qualifying first hospitalizations, 43,089 patients received early empiric antibiotics. Antibiotic use declined across all centers in the data collection period, from March 2020 (23%) to June 2022 (9.6%). Average rates of early empiric antibiotic use (EEAU) also varied significantly between centers (deviance explained 7.33% vs 20.0%, p < 0.001). Antibiotic use decreased slightly by day 2 of hospitalization and was significantly reduced by day 5. Mechanical ventilation before day 2 (odds ratio [OR] 3.57; 95% CI, 3.42–3.72), extracorporeal membrane oxygenation before day 2 (OR 2.14; 95% CI, 1.75–2.61), and early vasopressor use (OR 1.85; 95% CI, 1.78–1.93) but not region of residence was associated with EEAU. After propensity matching, EEAU was associated with an increased risk for in-hospital mortality (OR 1.27; 95% CI, 1.23–1.33), prolonged mechanical ventilation (OR 1.65; 95% CI, 1.50–1.82), late broad-spectrum antibiotic exposure (OR 3.24; 95% CI, 2.99–3.52), and late Clostridium difficile infection (OR 1.60; 95% CI, 1.37–1.87). CONCLUSIONS: Although treatment of COVID-19 patients with empiric antibiotics has declined during the pandemic, the frequency of use remains high. There is significant inter-center variation in antibiotic prescribing practices and evidence of potential harm. Our findings are hypothesis-generating and future work should prospectively compare outcomes and adverse events.

1 August 2024 in Physiological Measurement
Verified
Journal Article
Open access
PDF file
ABAndrew Barros
Andrew Barros
IMIan German Mesner
Ian German Mesner
NNN Rich Nguyen
N Rich Nguyen
J Randall MoormanJ Randall Moorman
J Randall Moorman
Objective. The 12-lead electrocardiogram (ECG) is routine in clinical use and deep learning approaches have been shown to have the identify features not immediately apparent to human interpreters including age and sex. Several models have been published but no direct comparisons exist. Approach. We implemented three previously published models and one unpublished model to predict age and sex from a 12-lead ECG and then compared their performance on an open-access data set. Main results. All models converged and were evaluated on the holdout set. The best preforming age prediction model had a hold-out set mean absolute error of 8.06 years. The best preforming sex prediction model had a hold-out set area under the receiver operating curve of 0.92. Significance. We compared performance of four models on an open-access dataset.

1 March 2021 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
ABAndrew Barros
Andrew Barros
CSCosti D. Sifri
Costi D. Sifri
TBTaison D. Bell
Taison D. Bell
JEJoshua C. Eby
Joshua C. Eby
KEKyle B. Enfield
Kyle B. Enfield
Respirators provide protection from airborne particles, and the N95 filtering facepiece respirator (FFR) is the most commonly used type in health care. Recent FFR shortages have led to increased interest in reusable elastomeric half-mask respirators (EHMRs),1,2 which have a flexible interface and larger straps than FFRs. Data from simulation and industrial settings suggests that EMHRs may provide higher respiratory protection than FFRs.3 Case reports in previous severe acute respiratory syndrome coronavirus pandemics have suggested transmission during cardiopulmonary resuscitation (CPR) despite FFR use,4 and simulation studies have demonstrated an unacceptable leak during CPR in up to 40% FFR users.5 Owing to shortages of FFR models, individuals who could not be fit in an available FFR model were fit for an EMHR. We assessed whether EHMRs provide improved fit during simulated CPR compared with FFRs.